Found: 25
Select item for more details and to access through your institution.
Expression of Concern: Delta-Like Ligand 4–Notch Blockade and Tumor Radiation Response.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 2044, doi. 10.1093/jnci/djae263
- Publication type:
- Article
Expression of Concern: Critical Role for Fas-Associated Death Domain–Like Interleukin-1–Converting Enzyme–Like Inhibitory Protein in Anoikis Resistance and Distant Tumor Formation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 2043, doi. 10.1093/jnci/djae264
- Publication type:
- Article
Response to Hu, Zhou, and Sun.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 2042, doi. 10.1093/jnci/djae258
- By:
- Publication type:
- Article
RE: Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 2040, doi. 10.1093/jnci/djae257
- By:
- Publication type:
- Article
Stat Bite: Observed and predicted all-cancer incidence and mortality rates and numbers in four Nordic countries: 1943-2040.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 2045, doi. 10.1093/jnci/djae248
- Publication type:
- Article
Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1961, doi. 10.1093/jnci/djae207
- By:
- Publication type:
- Article
Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B–Southwest Oncology Group 80702 (Alliance).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 2032, doi. 10.1093/jnci/djae203
- By:
- Publication type:
- Article
Intra-ethnic and geographic disparities in stage at diagnosis for non-small cell lung cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 2022, doi. 10.1093/jnci/djae199
- By:
- Publication type:
- Article
Lung cancer screening with low-dose computed tomography—where do we go from here?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1878, doi. 10.1093/jnci/djae197
- By:
- Publication type:
- Article
Academic readiness among young children treated for brain tumors: a multisite, prospective, longitudinal trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1952, doi. 10.1093/jnci/djae194
- By:
- Publication type:
- Article
A validated estimate of visceral adipose tissue volume in relation to cancer risk.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1942, doi. 10.1093/jnci/djae193
- By:
- Publication type:
- Article
Deciphering the sex gap in global life expectancy: the impact of female-specific cancers 1990-2019.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1934, doi. 10.1093/jnci/djae191
- By:
- Publication type:
- Article
Ambient ultraviolet A, ultraviolet B, and risk of melanoma in a nationwide United States cohort, 1984-2014.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1928, doi. 10.1093/jnci/djae186
- By:
- Publication type:
- Article
Expanding the list of cancers recognized to be caused by infectious agents.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1875, doi. 10.1093/jnci/djae185
- By:
- Publication type:
- Article
Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1871, doi. 10.1093/jnci/djae184
- By:
- Publication type:
- Article
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1979, doi. 10.1093/jnci/djae183
- By:
- Publication type:
- Article
Physical activity and cognition: longitudinal findings from the Thinking and Living with Cancer Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 2009, doi. 10.1093/jnci/djae182
- By:
- Publication type:
- Article
NCI workshop on ctDNA in cancer treatment and clinical care.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1890, doi. 10.1093/jnci/djae179
- By:
- Publication type:
- Article
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1914, doi. 10.1093/jnci/djae178
- By:
- Publication type:
- Article
Variation to biology: optimizing functional analysis of cancer risk variants.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1882, doi. 10.1093/jnci/djae173
- By:
- Publication type:
- Article
Risk factors for breast cancer subtypes by race and ethnicity: a scoping review.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1992, doi. 10.1093/jnci/djae172
- By:
- Publication type:
- Article
Social vulnerability and survival in 112 000 adolescents and young adults with cancer: a population-based study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 2003, doi. 10.1093/jnci/djae170
- By:
- Publication type:
- Article
Genomic instability in non–breast or ovarian malignancies of individuals with germline pathogenic variants in BRCA1/2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1904, doi. 10.1093/jnci/djae160
- By:
- Publication type:
- Article
Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1983, doi. 10.1093/jnci/djae159
- By:
- Publication type:
- Article
The risk and benefit profiles of US-eligible lung cancer screening attendees vs nonattendees.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 12, p. 1896, doi. 10.1093/jnci/djae148
- By:
- Publication type:
- Article